REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow Holding, Inc. (“HeartFlow” or the “Company”), the leader in revolutionizing precision heart care, today announced selected preliminary financial results for the period ended June 30, 2021 and provided updated guidance for the year ending December 31, 2021. […]
Tag: Heartflow
HeartFlow Announces Enrollment of First Three Patients in FUSION Trial
National Health Care Institute of the Netherlands-supported study to evaluate role of the HeartFlow Analysis in reducing unnecessary invasive procedures REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that physicians at Erasmus MC Hospital […]
HeartFlow Appoints John Farquhar as Chief Operating Officer
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of John Farquhar as Chief Operating Officer, effective August 4. In this newly established role, Mr. Farquhar will support the execution of HeartFlow’s strategic […]
HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company
Transforming the way heart disease is diagnosed and treated, HeartFlow’s artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients […]
Late-Breaking Data Confirm the Accuracy of the HeartFlow Planner in Modeling Post-PCI Outcomes
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced new data demonstrating the accuracy of the HeartFlow Planner in providing modeled post-percutaneous coronary intervention (PCI) fractional flow reserve derived from computed tomography (FFRct) values, which are […]
New 10-Year Data Demonstrate Superiority of the HeartFlow Analysis in Predicting Long-Term Outcomes in Patients With Coronary Artery Disease
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced new data which indicate that the information provided by the HeartFlow FFRct Analysis was a superior predictor of 10-year outcomes compared to the severity of a coronary […]
HeartFlow Announces Completion of Patient Enrollment in the PRECISE Trial
2,100 patients enrolled in randomized controlled trial to evaluate a precision-testing pathway for suspected coronary artery disease REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced the completion of patient enrollment in the Prospective Randomized Trial of the Optimal Evaluation […]
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve […]
NICE Renews Support for Use of AI-powered HeartFlow Analysis in Heart Disease Diagnosis
The National Institute for Health and Care Excellence (NICE) finds HeartFlow Analysis can save NHS England as much as £391 per patient The digital technology is reducing reliance on unnecessary invasive diagnostic procedures and is cutting hospital waiting times The announcement follows NHS […]
New JAMA Network Open Publication Demonstrates the Coronary CT- HeartFlow Analysis Pathway Is ‘Dominant’ Compared to Stress Testing in Cost-Effectiveness Analysis
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, announced that a new cost-effectiveness analysis found a diagnostic pathway which utilizes coronary computed tomography angiography (CTA) with the HeartFlow FFRct Analysis to be “dominant” (less costly and more […]
Recent
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Popular
- No commented posts yet